梅州急性附件炎严重吗梅州做超导可视人流价格,梅州怎么治疗滴虫性阴道炎,梅州怎样才能去除双下巴,梅州全脸做脂肪填充,梅州做双眼皮开刀,梅州眼皮下垂做手术,梅州宫颈糜烂手术费多少钱

SINGAPORE, Oct. 10 (Xinhua) -- A Singapore start-up firm has devised an innovative application to allow phone users to have access to their positioning information within buildings, where traditional global positioning system has often proved inaccurate, local daily Business Times reported on Monday.The firm YFind Positioning System feels that the application can help turn Singapore into the world's first location- intelligent city.Ting See Ho, co-founder of the firm, said the application works by first verifying the GPS coordinates to identify the building the user is in, and then collecting RSSI (received signal strength information) readings off WiFi access points within the building.The information is then sent by the phone to the central positioning server for comparison against records of the radio map of the building, which is calibrated earlier by the company.Ting said the RSSI readings continually fluctuates, making it difficult to estimate a position. This is where YFind Positioning System steps in with its patent-pending probabilistic algorithms to help accurately estimated the user's indoor positions.Once the phone application determines the location, then, it is able to map a course for a shop or other destination within the building where the user wants to go."You can think of it as creating an 'indoor GPS' environment in the buildings where satellite signals cannot be read," Ting said.He said that more than ten organizations in Singapore have approached the company to discuss deployment and partnerships and that it has begun work on three proof-of-concepts.The company's immediate goal is to make Singapore the world's first location-intelligent city before going to other cities, he said.

SAN FRANCISCO, Oct. 14 (Xinhua) -- Google on Friday announced to shut down the highly-controversial social networking product Google Buzz, along with several other services in the coming weeks.On the company's official blog, Google announced the death penalty to its code search engine, Buzz, Jaiku which let users send updates to friends, the Google personalized homepage feature iGoogle, and the University Research Program for Google Search.The shut-downs came as part of Google's housecleaning effort announced in early September, in which the company said it will shut down a number of products and merging others into existing products as features."Changing the world takes focus on the future, and honesty about the past. We learned a lot from products like Buzz, and are putting that learning to work every day in our vision for products like Google+. Our users expect great things from us; today's announcements let us focus even more on giving them something truly awesome," said Google in the blog post.Google Buzz, a social networking and messaging tool integrated into Gmail service, has been widely criticized for privacy concerns and held back the search giant from expanding its businesses to the social networking space.After Buzz, Google launched Google+ in June, which has been receiving a good response and passed the 40 million user mark, the company's chief executive officer Larry Page said Thursday.

BEIJING, Oct. 12(Xinhuanet) -- People allergic to peanuts may find relief in a new research by American scientists, according to Huffington Post Monday.Scientists from the Northwestern University Feinberg School of Medicine have found a way to turn off allergic responses by creating an immune system tolerant to peanuts.They attached peanut proteins, the source of the allergy, to white blood cells of mice. Then the mice's immune systems would recognise the proteins and become tolerant to them.When people eat peanuts, allergic human bodies would recognize peanut proteins as invading pathogens and trigger immune responses like throat swelling, even closing up, which can be lethal. Ditto for mice's bodies.But when peanut protein attached to the body's own cells, the immune systems would regard the peanut proteins as perfectly normal and not attack the cells, said Paul Bryce, an assistant professor involved in the study. Then the allergic responses disappeared.The research was conducted on mice. But the scientists expected the method to cure peanut allergies could apply to humans, according to Huffington Post.Although the research was promising, it did not mean that peanut allergies in humans could be actually cured in the foreseeable future, said Dr. Clifford Basset medical director at Allergy and Asthma Care of New York, to ABC News, "Its all about education, prevention and preparedness".

ting fuel and benefits to agriculture from extended growing seasons."Global mitigation leading to a low climate change future reduces costs to Canada in the long term. This reinforces the argument that Canada would benefit environmentally and economically from a post 2012 international climate arrangement that systematically reduced emissions from all emitters - including Canada - over time," the report says.It recommends cooperation between governments, scientists and businesses to find ways to mitigate climate change and adapt to it.Canada's Minister of the Environment Peter Kent said the government has a plan to deal with global warming issues, which will be announced next month."Our government has a plan, a very good plan, to meet our target of reducing greenhouse gases by 17 percent from 2005 base levels, by 2020," Kent told Canada's House of Commons Thursday afternoon."We are moving forward to reduce greenhouse gases and, at the same time, we are investing in programs to help Canadians adapt to climate change," Kent said."Today's report merely echoes what our government has long recognized; that is, the importance of adaptation to climate change," he added.Earlier this week, several hundred people protested the government's policy of exploiting the oil sands deposits in western Canada.Environmentalists have criticized the Canadian government for not working hard enough to reduce CO2 emissions. Last year, a coalition of global warming activists gave Canada the "Fossil of the Year" award for failing to implement the Copenhagen Accord.

WASHINGTON, Oct. 13 (Xinhua) -- In a trial that included about 35,000 men, those who were randomized to receive daily supplementation with vitamin E had a significantly increased risk of prostate cancer, according to a study published this week in the Journal of the American Medical Association.The study followed more than 35,533 men 50 or older at 427 sites in the United States, Canada and Puerto Rico. The men were divided into four groups who took daily doses of 400 international units of Vitamin E and 200 micrograms of selenium; Vitamin E and a placebo that looked like selenium; selenium and a placebo that looked like Vitamin E; or two placebos. The recommended daily intake of Vitamin E is about 22.4 international units.The researchers from the Cleveland Clinic found that the rate of prostate cancer detection was greater in all treatment groups when compared with placebo but was statistically significant only in the vitamin E alone group -- a 17 percent increased rate of prostate cancer detection. The difference in rates of prostate cancer between vitamin E and placebo became apparent during the participants' third year in the trial. The elevated risk estimate for vitamin E was consistent across both low- and high-grade disease."The observed 17 percent increase in prostate cancer incidence demonstrates the potential for seemingly innocuous yet biologically active substances such as vitamins to cause harm. The lack of benefit from dietary supplementation with vitamin E or other agents with respect to preventing common health conditions and cancers or improving overall survival, and their potential harm, underscore the need for consumers to be skeptical of health claims for unregulated over-the-counter products in the absence of strong evidence of benefit demonstrated in clinical trials," the researchers said.